Clinical Trial Update: A Study of Olaparib and Low Dose Radiotherapy for Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating olaparib with low-dose radiotherapy for small cell lung cancer has completed. The trial investigates feasibility and safety of the comb…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Olaparib (Olaparib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Small-cell Lung Cancer, Small Cell Lung Carcinoma | Phase 1 | Status: COMPLETED